SOST and type 2 diabetes mellitus: Sclerostin is a monomeric glycoprotein expressed by the SOST gene in osteocytes and appears to play an important role in the regulation of bone remodeling by inhibiting canonical Wnt/β-catenin signaling, particularly in those with T2DM [39].